NCT05085457

Brief Summary

Patients on mechanical ventilation (MV) must undergo weaning, an interruption of ventilatory support. Several scores have been developed to predict this outcome, but the failure index in weaning and extubation remains high. The aim of this study is to evaluate the effect of ExPreS - Extubation Predictive Score - on the rate of successful extubation. This research will be conducted in a randomized clinical trial in ICUs of several hospitals. It is expected that there will be a difference between devices for predicting extubation success, and because ExPreS is a protocol that evaluates various parameters related to many organs and systems, it has a better ability to predict extubation success in MV patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
540

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 20, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

November 14, 2025

Status Verified

February 1, 2025

Enrollment Period

3.2 years

First QC Date

October 7, 2021

Last Update Submit

November 13, 2025

Conditions

Keywords

Mechanical VentilationExtubationWeaning

Outcome Measures

Primary Outcomes (1)

  • Extubation Success

    No reintubation nor dependence of NIV

    48 hours

Secondary Outcomes (5)

  • Reintubation

    28 days

  • IMV lenght of stay

    28 days

  • ICU lenght of stay

    28 days

  • Hospital lenght of stay

    28 days

  • In Hospital mortality

    28 days

Study Arms (2)

Control Group

NO INTERVENTION

On group I (T-ayre and standard protocol), SBT must begin with the pacient in T-ayre, oxygen support that is proprotional to the fraction of inspired oxygen in invasive mechanical ventilation (IMV), during 30 minutes. If the pacient does not show any sign of SBT failure, the rapid shallow beathing index (RSBI) will be calculated and pacients with RSBI lower than 105 L/min will be extubated, meanwhile pacients with RSBI higher than 105 L/min will return to MV for at least 24 hours until the perfomance of a new SBT.

ExPreS Group

EXPERIMENTAL

On group II (T-ayre and ExPreS protocol), the pacient will be submitted to the SBT with T-ayre, with oxygen support that is proprotional to the fraction of inspired oxygen in IMV, during 30 minutes. If the pacient does not show any sign of SBT failure, ExPreS will be calculated. If punctuation is lower than or equal to 44, it indicates weaning failure and the pacient mjust return to MV for 24 hours at least. Punctuation between 45 and 58 must be evaluated if the pacient presents chronic obstructive pulmonary desease (COPD), obesity or heart desease. In this case, the weaning must be continued if there isn't any risck factors. Punctuation higher than or equal 59 indicates that the pacient can be extubated.

Diagnostic Test: ExPreS Protocol

Interventions

ExPreS ProtocolDIAGNOSTIC_TEST

the pacient will be submitted to the SBT with T-ayre, with oxygen support that is proprotional to the fraction of inspired oxygen in IMV, during 30 minutes. If the pacient does not show any sign of SBT failure, ExPreS will be calculated. If punctuation is lower than or equal to 44, it indicates weaning failure and the pacient mjust return to MV for 24 hours at least. Punctuation between 45 and 58 must be evaluated if the pacient presents chronic obstructive pulmonary desease (COPD), obesity or heart desease. In this case, the weaning must be continued if there isn't any risck factors. Punctuation higher than or equal 59 indicates that the pacient can be extubated.

ExPreS Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pacients admitted in ICU that are more than 18 years;
  • MV for more than 24 hours;
  • Assignature of the free and informed consent form by a family member or responsable adult.

You may not qualify if:

  • Death before SBT;
  • Tracheostomy;
  • Self-extubation;
  • Accidental extubation;
  • Absence of signature of informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitário Santa Terezinha

Joaçaba, Santa Catarina, 89600-000, Brazil

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participant will not know if the ExPreS or just RSBI were calculated before extubation. The SBT will be the same for both groups. Investigator and outcomes assessor will not have access to whole patients' data, just the primary and secundary outcomes to perform the statistical analysis.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Patients will be randomized to receive the intervation of Control group or ExPreS group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 7, 2021

First Posted

October 20, 2021

Study Start

November 1, 2021

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

November 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations